[Acute coronary syndrome, a rare complication of human immunoglobulin therapy].
Human immunoglobulin is being increasingly used in the treatment of autoimmune diseases. Despite being rare, thromboembolic complications like acute coronary syndrome (ACS) are possible and not reported in our country's literature. The authors present a case report of a 39 years old patient who developed an ACS after treatment of immune thrombocytopenic purpura with human immunoglobulin. A brief review of risk factors and mechanisms of this complication is performed.
Providência
Rui
R
Serviço de Cardiologia, Centro Hospitalar de Coimbra, Portugal. rui_providencia@yahoo.com
Fortuna
Jorge
J
Pereira
Alexandra Alves
AA
Mota
Paula
P
Leitão-Marques
A M
AM
D054058:Acute Coronary Syndrome / Q000139:chemically induced*; D000328:Adult; D006801:Humans; D007136:Immunoglobulins / Q000009:adverse effects*; D008297:Male
D007136:Immunoglobulins